Home LiteratureArticle Details
PMID: 6403103 Published · ppublish English Case Reports Journal Article

Factors related to first dose hypotensive effect of captopril: prediction and treatment.

British medical journal (Clinical research ed.) ·Vol. 286 ·No. 6368 ·1983-03-12 ·Pages 832-4

Hodsman GP, Isles CG, Murray GD, Usherwood TP, Webb DJ, Robertson JI

Abstract

The blood pressure response to the first dose of captopril (6.25 mg, 12.5 mg, or 25 mg) was measured in 65 treated, severely hypertensive patients. Mean supine blood pressure was 187/108 mm Hg immediately before captopril was given. Twenty one patients experienced a fall in supine systolic pressure greater than 50 mm Hg, including five whose pressure fell more than 100 mm Hg and two whose pressure fell more than 150 mm Hg. Six patients developed symptoms of acute hypotension, including dizziness, stupor, dysphasia, and hemiparesis. Percentage reductions in blood pressure were greatest in those with secondary hypertension (p less than 0.05), high pretreatment blood pressure (p less than 0.05), and high concentrations of plasma renin and angiotensin II (p less than 0.01). No significant correlation was found between fall in blood pressure and serum sodium concentration, age, renal function, and the dose of captopril given. A severe first dose effect cannot be consistently predicted in individual patients who have received other antihypertensive drugs for severe hypertension. Such patients should have close medical supervision for at least three hours after the first dose of captopril.

MeSH Terms
Aged Angiotensin II/blood Captopril/administration & dosage,adverse effects Creatinine/blood Dose-Response Relationship, Drug Female Humans Hypertension/blood,drug therapy Hypotension/chemically induced Male Middle Aged Proline/analogs & derivatives Renin/blood Sodium/blood
Chemicals
Angiotensin II Proline Captopril Sodium Creatinine Renin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hodsman G P
Isles C G
Murray G D
Usherwood T P
Webb D J
Robertson J I
References (17)
17 references, click to expand
  1. Renin relationships in congestive cardiac failure, treated and untreated.
    Am Heart J. 1970 Sep;80(3):329-42 PMID: 5452310
  2. Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.
    Eur J Clin Invest. 1971 Nov;2(1):32-8 PMID: 4333501
  3. Calibration and evaluation of a system of total body in vivo activation analysis using 14 MeV neutrons.
    Phys Med Biol. 1978 May;23(3):405-15 PMID: 97681
  4. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.
    Prog Cardiovasc Dis. 1978 Nov-Dec;21(3):195-206 PMID: 214819
  5. A microassay for active and total renin concentration in human plasma based on antibody trapping.
    Clin Chim Acta. 1980 Feb 14;101(1):5-15 PMID: 6987010
  6. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.
    Hypertension. 1980 Jul-Aug;2(4):586-93 PMID: 6156900
  7. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Br Heart J. 1980 Sep;44(3):290-6 PMID: 7000102
  8. The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme.
    Clin Sci (Lond). 1980 Jun;58(6):445-50 PMID: 6253115
  9. Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect.
    Clin Sci (Lond). 1980 Dec;59(6):451-6 PMID: 7002436
  10. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
    Clin Exp Pharmacol Physiol. 1980 Sep-Oct;7(5):487-91 PMID: 7004680
  11. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
    Jpn Heart J. 1980 Nov;21(6):793-802 PMID: 7007685
  12. Use of captopril in the diagnosis of renal hypertension.
    Aust N Z J Med. 1981 Aug;11(4):359-63 PMID: 7030291
  13. Hyponatraemia as a marker for high renin heart failure.
    Br Heart J. 1982 Feb;47(2):161-6 PMID: 7037024
  14. Captopril in renovascular hypertension: long-term use in predicting surgical outcome.
    Br Med J (Clin Res Ed). 1982 Mar 6;284(6317):689-93 PMID: 6802290
  15. Clinical experience with captopril in the treatment of severe drug-resistant hypertension.
    Am J Cardiol. 1982 Apr 21;49(6):1475-9 PMID: 7041586
  16. Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
    Eur Heart J. 1982 Jun;3(3):255-9 PMID: 6809465
  17. PLASMA RENIN CONCENTRATION IN HUMAN HYPERTENSION. 1. RELATIONSHIP BETWEEN RENIN, SODIUM, AND POTASSIUM.
    Br Med J. 1965 Jul 17;2(5454):144-8 PMID: 14306581
Article Info
Journal
British medical journal (Clinical research ed.)
Abbr.
Br Med J (Clin Res Ed)
ISSN
0267-0623
Published
1983-03-12
Pages
832-4
Language
English
Region
England
NLM ID
8302911
PMCID
PMC1547159
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com